Clinical study on SY5555

We evaluated the clinical efficacy and safety of SY5555, a new oral penem. SY5555 was administered to 8 patients with respiratory tract infections: 2 with acute tonsillitis, 1 with chronic tonsillitis, 2 with chronic bronchitis, 2 with bronchiectasis and 1 with pneumonia. Clinical efficacy was good...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 42; no. Supplement1; pp. 706 - 707
Main Authors Wada, Koichi, Sega, Hiroyuki, Yoshikawa, Hiroko, Arakawa, Masaaki
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1994
Online AccessGet full text

Cover

More Information
Summary:We evaluated the clinical efficacy and safety of SY5555, a new oral penem. SY5555 was administered to 8 patients with respiratory tract infections: 2 with acute tonsillitis, 1 with chronic tonsillitis, 2 with chronic bronchitis, 2 with bronchiectasis and 1 with pneumonia. Clinical efficacy was good in all cases. The bacteriological response was “eradicated” in 2 patients and “reduced” in 1 case. Neither side effects nor abnormal laboratory findings due to SY5555 were observed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.42.Supplement1_706